EnteroMedics raises about $12 million for obesity device

03/5/2013 | MassDevice.com (Boston)

EnteroMedics has raised net proceeds of about $12 million in a public offering. The St. Paul, Minn.-based company will use the money to seek FDA approval for its Maestro RC system, which uses vagal nerve blocking to help treat patients with obesity, as well as to market the product outside the U.S.

View Full Article in:

MassDevice.com (Boston)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Director, Biostatistics
Edwards Lifesciences
Irvine, CA
Diagnostic Technician
Roche
Marlborough, MA
Test Technician
Roche
Marlborough, MA
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC
Senior Paralegal - Research & Development, and Medical
Boehringer Ingelheim
Ridgefield, CT